natriuretic peptides in congestive heart failure increased circulating concentrations of atrial natriuretic peptide - BNP andheart failure and Natriuretic Peptides in Congestive Heart Failure: A Comprehensive Overview

Peptidesforheart failure Natriuretic peptides are crucial hormones that play a significant role in the body's response to congestive heart failure (CHF). These peptides are primarily released from the heart muscle in response to increased pressure or stretch within the cardiac chambers作者：SJ Sangaralingham·2022·被引用次数：64—3.2Natriuretic peptides improve microcirculatory perfusionthrough vasodilating and proangiogenic actions. Apart from neurohumoral imbalance, another mechanism .... Their activation in heart failure signifies the body's attempt to counteract the detrimental effects of the condition. Understanding the function and measurement of natriuretic peptides is vital for accurate diagnosis, effective management, and improved prognosis in patients with heart failure.Natriuretic Peptides in Heart Failure: Improving Diagnosis ...

The Role and Types of Natriuretic Peptides

Natriuretic peptides (NPs) are a family of hormones produced by the heart. They are released in response to distension (stretch) or inflammation within the heart muscle. Three main types of NPs are relevant to cardiac function:

* Atrial natriuretic peptide (ANP): This hormone is released from myocardial cells in the atria and, in some cases, the ventricles, in response to elevated cardiac filling pressures. ANP in heart failure is often elevated as the atria stretch due to fluid overload.

* B-type natriuretic peptide (BNP): Primarily synthesized and secreted by the ventricular myocytes, BNP is strongly induced during episodes of ventricular stretch. BNP levels are highly correlated with increasing congestive heart failure (CHF) severity作者：J Koglin·2001·被引用次数：708—Infusionofsynthetic BNP in patientswithchronicheart failurehas been shown to decrease pulmonary capillary wedge pressure, diminish systemic vascular .... In fact, B-type natriuretic peptide >100 pg/ml is the cutoff for diagnosing congestive heart failure in symptomatic patients.

* C-type natriuretic peptide (CNP): While also a natriuretic peptide, CNP's role in CHF is less understood compared to ANP and BNP.

The natriuretic peptide system consists of these structurally similar peptides that compensate for changes in volume and pressure within the cardiovascular system.

Mechanisms of Action and Cardioprotective Effects

Natriuretic peptides exert several beneficial effects that are particularly important in the context of heart failure:

* Diuresis and Natriuresis: A primary function of NPs is to promote the excretion of sodium (natriuresis) and water (diuresis) by the kidneys.2021年3月9日—Initial studies demonstrated that brain natriuretic peptide (BNP) levels were highly correlated with increasing congestive heart failure (CHF) ... This helps to reduce fluid overload, a common symptom of heart failureNatriuretic Peptides in Heart Failure: Improving Diagnosis ....

* Blood Pressure Reduction: NPs cause vasodilation, leading to a decrease in blood pressure. This effect helps to reduce the workload on the compromised heart.

* Cardioprotection: Beyond their direct hemodynamic effects, natriuretic peptides possess cardioprotective properties.B-Type Natriuretic Peptide (BNP) Test - Cleveland Clinic They exhibit anti-apoptotic (preventing cell death) and anti-fibrotic (inhibiting scar tissue formation) actions, which can help preserve heart muscle function.

* Improved Microcirculation: Natriuretic peptides improve microcirculatory perfusion through vasodilating and proangiogenic actions, enhancing blood flow to vital tissues.

These overall effects of NPs, including increased diuresis and natriuresis, blood pressure reduction, anti-apoptotic and anti-fibrotic actions, contribute significantly to the body's compensatory mechanisms in heart failure.

Diagnostic and Prognostic Significance

The measurement of natriuretic peptides has become indispensable in the diagnosis and management of heart failure.

* Diagnosis of Heart Failure: BNP tests or NT-proBNP tests are mainly used to help diagnose or rule out heart failure in individuals experiencing symptoms like shortness of breath. High levels can be a sign of heart failure.Cardiac Natriuretic Peptides Cardiac Failure - Cardiac Failure Review For instance, Normal brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels are helpful in excluding chronic heart failure in ambulatory settingsNatriuretic Peptides: Role in the Diagnosis and .... The natriuretic peptide measurement can help confirm or rule out a diagnosis of heart failure and potentially shorten emergency room visits.作者：LB Daniels·2007·被引用次数：1639—B-type natriuretic peptide >100 pg/ml is the cutoff for diagnosing congestive heart failurein symptomatic patients. Stage A = risk factors; Stage B = ...

* Distinguishing Causes of Dyspnea: Elevated NP levels are particularly useful in differentiating cardiac causes of dyspnea from non-cardiac causes.

* Severity Assessment and Prognosis: Higher ANP and BNP levels are associated with the restrictive filling pattern seen in certain types of heart failure. Furthermore, BNP and NT-proBNP levels serve as important prognostic biomarkers, indicating the severity of the disease and predicting future outcomes.

* Heart Failure with Preserved Ejection Fraction (HFpEF): Plasma NT-proBNP (N-terminal pro-B-type natriuretic peptide) is commonly used to diagnose heart failure with preserved ejection fraction (HFpEF).

* Risk Stratification: Natriuretic peptides have become important diagnostic and prognostic biomarkers in cardiovascular diseases, particularly in heart failure (HF). They are important tools to establish diagnosis and prognosis in heart failure (HF).

Challenges and Considerations in Interpretation

While invaluable, interpreting natriuretic peptide levels requires consideration of certain factors:

* Body Mass Index (BMI): Research suggests that the current recommended NT-proBNP rule-out threshold of 125 ng/L performed suboptimally, particularly in patients with BMI ≥35 kg/m².2016年3月22日—Today, natriuretic peptides are ubiquitously utilized for the diagnosis, treatment, and prognostication of heart failure in the Emergency ... Adjustments may be necessary for individuals with obesity.

* Age and Renal Function: Age and kidney function can influence NP levels, requiring careful interpretation in specific patient populations.

Conclusion

Natriuretic peptides are integral to the body's response to congestive heart failure2023年12月4日—A BNP test or an NT-proBNP testis mainly used to help diagnose or rule out heart failurein a person who is having symptoms.. Their diagnostic and prognostic utility, coupled with their beneficial physiological effects, has cemented their role in modern cardiovascular medicine. From aiding in the diagnosis and management of heart failure to providing crucial prognostic information, these hormones are indispensable tools for clinicians caring for patients with cardiac conditions作者：J Koglin·2001·被引用次数：708—Infusionofsynthetic BNP in patientswithchronicheart failurehas been shown to decrease pulmonary capillary wedge pressure, diminish systemic vascular .... The ongoing research into natriuretic peptides in heart failure continues to refine our understanding and application of these vital biomarkersheart failure Role of brain natriuretic peptide in risk ....